Search

You searched for "tear"

2412 results found

Building leaders for eye care in Africa: the COECSA-RCOphth VISION 2020 LINK

1 April 2015 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
The VISION 2020 LINK [1] between the College of Ophthalmology of Eastern, Central and Southern Africa (COECSA) and the Royal College of Ophthalmologists (RCOphth) has been building leaders of eye care in Africa since 2008, when a Memorandum of Understanding...

Gene therapy for inherited retinal disease: the Manchester Ocular Gene Therapy Group MDT service

4 August 2021 | | EYE - Paediatrics, EYE - Vitreo-Retinal, EYE - General
The authors describe the process set up in Manchester for the optimum delivery and assessment of a new gene therapy treatment for patients with RPE65 IRD. Inherited retinal dystrophies (IRDs) are the second commonest cause of severe visual impairment in...

New national programme of sight tests in special schools

12 February 2020
As a result of SeeAbility’s campaigning, NHS England are planning for a new national programme of sight tests and glasses dispensing in England’s special schools from 2020. SeeAbility’s model of sight testing is less stressful for children with learning disabilities...

REPORT: American-European Congress of Ophthalmic Surgery (AECOS) European Symposium

17 August 2022
David Shahnazaryan, Consultant Ophthalmologist, London, UK and Radhika Rampat, Consultant Ophthalmologist, London, UK, report from the AECOS Symposium in Antwerp, Belgium (June 10-12).

Sight loss charities appoint new director of operations

31 August 2023 | infrastructure, Sight Scotland, Sight Scotland Veterans
Sight Scotland and Sight Scotland Veterans have appointed Gillian McDonald as their new Director of Operations.

The National Treatment Centre-Highland

8 September 2023 | National Treatment Centre-Highland, Andy Pyott, Scotland, Eyecare, Raigmore, NHS Highland
The National Treatment Centre-Highland opened its doors to patients in April 2023. At a cost of £48 million this represented a significant investment by the Scottish Government for the provision of modern eye care for the North of Scotland.

BELKIN Vision is pleased to announce FDA clearance for its glaucoma laser, the Eagle device

14 December 2023 | SLT, DSLT, the eagle, Belkin, Glaucoma, Laser therapy, USA
BELKIN Vision, an innovator in ophthalmic medical solutions, is pleased to announce that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its glaucoma laser, the Eagle device.

Coventry Community Eye Hospital recognised as ‘Outstanding’

5 January 2024 | CHEC, community services, ophthalmology, hospital, rating, UK, Coventry
Care and Quality Commission awards CHEC highest possible rating.

WE KNOW THAT YOU ARE MORE THAN MEETS THE EYE

23 January 2024 | Sight Scotland, Charity, Campaign, Awareness, sight impairment
Charity’s new campaign aims to dispel negative perceptions of people living with sight loss.

SPOKE launches Indicative Guidance for contact lens opticians and independent prescribers

20 February 2024 | GOC, ABDO, Optometrist, education
The Sector Partnership for Optical Knowledge and Education (SPOKE) has published two new Indicative Guidance documents.

Hertfordshire and West Essex ICB accredits CHEC as a system provider of gastroenterology services

2 May 2024 | CHEC, community, eyecare, healthcare, services, private, industry
CHEC Stevenage, a community-based hospital, aims to increase patient choice and maintain short waiting times.

New study uncovers key mechanism behind a common genetic cause of age-related visual loss

19 September 2024 | endothelial cells, age, vision loss, research, academic, new, genetics, genome, Fuchs Endothelial Corneal Dystrophy, FECD
A groundbreaking study has revealed important insights into the mechanisms behind Fuchs Endothelial Corneal Dystrophy (FECD), a common cause of age-related visual loss, providing hope for future therapeutic developments, and finding implications for other neurological diseases. FECD is a common,...